col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Frontiers Media SA: Frontiers in Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―22 Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein Bingqian Li, Lin Wang, Huan Ge, Xianglei Zhang, Penxuan Ren, Yu Guo, et al. (+6)
2 [GO] 2021―Jun―24 Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease Juliana C. Ferreira, Samar Fadl, Adrian J. Villanueva, Wael M. Rabeh
3 [GO] 2021―May―10 Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics Shailima Rampogu, Keun Woo Lee
4 [GO] 2021―May―04 Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor Ahmed A. Al-Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly, Sameh S. Elhady, Eslam B. Elkaeed, Ibrahim H. Eissa, Khaled M. Darwish
5 [GO] 2021―Apr―28 Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs Annalisa Tito, Antonio Colantuono, Luciano Pirone, Emilia Pedone, Daniela Intartaglia, Giuliana Giamundo, et al. (+3)
6 [GO] 2021―Mar―29 Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study Pradeep Kumar Yadalam, Kalaivani Varatharajan, K. Rajapandian, Priyanka Chopra, Deepavalli Arumuganainar, Thilgavathi Nagarathnam, et al. (+2)
7 [GO] 2021―Mar―12 Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin
8 [GO] 2021―Feb―07 In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease Osvaldo Yañez, Manuel Isaías Osorio, Eugenio Uriarte, Carlos Areche, William Tiznado, José M. Pérez-Donoso, et al. (+2)
9 [GO] 2021―Feb―04 In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease Tien Huynh, Wendy Cornell, Binquan Luan
10 [GO] 2021―Jan―21 Computational Characterizations of the Interactions Between the Pontacyl Violet 6R and Exoribonuclease as a Potential Drug Target Against SARS-CoV-2 Rangika Munaweera, Ying S. Hu
11 [GO] 2021―Jan―14 Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease Chandrabose Selvaraj, Umesh Panwar, Dhurvas Chandrasekaran Dinesh, Evzen Boura, Poonam Singh, Vikash Kumar Dubey, Sanjeev Kumar Singh
12 [GO] 2021―Jan―13 Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences Mei Yang, Suhua He, Xiaoxue Chen, Zhaoxia Huang, Ziliang Zhou, Zhechong Zhou, et al. (+3)
13 [GO] 2021―Jan―05 Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations Sugunadevi Sakkiah, Wenjing Guo, Bohu Pan, Zuowei Ji, Gokhan Yavas, Marli Azevedo, et al. (+3)
14 [GO] 2020―Dec―23 Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2 Renata Abel, María Paredes Ramos, Qiaofeng Chen, Horacio Pérez-Sánchez, Flaminia Coluzzi, Monica Rocco, et al. (+6)
15 [GO] 2020―Dec―10 Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins Flavia Squeglia, Maria Romano, Alessia Ruggiero, Giovanni Maga, Rita Berisio
16 [GO] 2020―Dec―08 Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay Eleni Pitsillou, Julia Liang, Katherine Ververis, Kah Wai Lim, Andrew Hung, Tom C. Karagiannis
17 [GO] 2020―Nov―19 Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline Krishnasamy Gopinath, Elmeri M. Jokinen, Sami T. Kurkinen, Olli T. Pentikäinen
18 [GO] 2020―Nov―16 Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease Pietro Delre, Fabiana Caporuscio, Michele Saviano, Giuseppe Felice Mangiatordi
19 [GO] 2020―Nov―05 Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking Tamer M. Ibrahim, Muhammad I. Ismail, Matthias R. Bauer, Adnan A. Bekhit, Frank M. Boeckler
20 [GO] 2020―Oct―30 Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations Mahmoud A. El Hassab, Aly A. Shoun, Sara T. Al-Rashood, Tarfah Al-Warhi, Wagdy M. Eldehna
21 [GO] 2020―Oct―23 Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain Adriana Carino, Federica Moraca, Bianca Fiorillo, Silvia Marchianò, Valentina Sepe, Michele Biagioli, et al. (+7)
22 [GO] 2020―May―27 Development of Point-of-Care Biosensors for COVID-19 Jane Ru Choi


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec